Dynamic cultivation of scaffolds loaded with undifferentiated stem cells can lead toward osteogenic differentiation in vivo. The aim of this study was to examine the influence of different in vitro cultivation setups on the integration of cell-matrix constructs after subcutaneous implantation. Human mesenchymal stem cells (hMSC) were inoculated on clinically approved scaffolds. These cell-matrix constructs were then cultured under static (12 hours or 14 days) or dynamic (14 days) conditions, followed by paravertebral subcutaneous implantation in athymic nude mice. After 2 weeks and 12 weeks the constructs and selected organs were harvested for histological evaluation, and qualitative and quantitative polymerase chain reaction (PCR). Histological analysis showed good integration of cell-matrix constructs independent of culture conditions and a differential effect of static and dynamic in vitro culture on fat cell formation in vivo. Human DNA (hDNA) was detected in explanted cell-matrix constructs at all time points with a significant decrease in human cells on the constructs compared to the initial amount of cells seeded. No hDNA was detected in the explanted organs. In conclusion, we could prove the survival of hMSC on scaffolds after in vitro cultivation and consecutive implantation in vivo. While the amount of adipose tissue increased after static cultivation, we could not achieve osteogenic differentiation.
INTRODUCTION B
ONE DEFECTS CAUSED BY TRAUMA, tumors, or malformations still represent a major problem in reconstructive surgery. In the context of promising tissue engineering strategies, Vacanti et al. successfully reconstructed the distal phalanx of an amputated finger in a clinical experiment. Scaffolds were seeded with autologous cells that were cultivated in vitro prior to implantation. 1 However, the relatively poor clinical result paired with a time-consuming approach and therefore high operative stress for the patient do not justify wide clinical use of this approach. 2 More experimental research is needed to improve tissue engineering applications in this direction.
Graft materials are vitalized by cells in vitro prior to implantation into sites where formation of new tissue is needed. Much attention is paid to human mesenchymal stem cells (hMSC) because of their ability to progress from undifferentiated progenitors to biosynthetically mature cells and their self-renewing capacity. 3, 4 Although ectopic as well as orthotopic bone formation has been observed in many preclinical animal models following implantation of 3D cellmatrix constructs, many issues, such as the recruitment and manipulation of an adequate cell population, choice of a suitable scaffold, and an effective initiation of osteogenesis still remain to be solved. [5] [6] [7] [8] To achieve new bone formation, implanted stem cells must differentiate toward osteoblastic cells, because these cells are crucial for the synthesis and deposition of new bone. To support this process, influence can be exerted in vitro to favor a certain lineage rather than allowing the cells to differentiate along all the lineages possible. Following expansion of cells, it is essential that they are seeded successfully onto suitable scaffolds. In this study we focus on the influence of the in vitro culture period on the in vivo integration of cell-matrix constructs after subcutaneous implantation. Some studies claim that cultivation of cell-matrix constructs in flow perfusion chambers enhances osteoblastic differentiation even without the addition of osteogenic supplements such as dexamethasone as opposed to static culture conditions in vitro. [9] [10] [11] Presumably, in the former case, shear forces promote undifferentiated stem cells to differentiate toward the osteogenic lineage. However, implantation of cell-matrix constructs in a calvarian defect model did not show differences in bone formation as a result of different culture conditions. The highest percentage of bone formation per implant was seen after static cultivation or flow perfusion for 1 day in vitro.
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Further, it is essential that implanted cells do not disseminate or exhibit unwanted cell growth afar the implantation site. Evidence exists that hMSC appear in neuronal tissue and other organs of the host following intravenous injection. 13 Also, cells injected intraperitoneally into inbred mouse embryos were detected in all harvested organs. To date no experimental study has examined the dissemination of hMSC in host organs following subcutaneous implantation.
Therefore, this study aimed to (i) examine the influence of the in vitro cultivation period on the in vivo performance of cell-matrix constructs after their subcutaneous implantation, and (ii) detect any migration of cells from the implantation site to organs of the host. To rule out the influence of osteoconduction, periosteal bone formation, and biomechanical features as seen in orthotopic implantation sites, we used a heterotopic model.
MATERIALS AND METHODS

Scaffold loading and cultivation of hMSC
The hMSC (Cambrex, Walkersville, USA) were cultivated in MSC basal medium (Cambrex). Fresh medium was supplied three times a week. When cell layers neared confluence, cells were detached using trypsin-EDTA. Cultures were maintained in a humidified atmosphere of 95% air with 5% carbon dioxide (CO 2 ) at 378C.
Cells in the fifth passage were trypsinized, centrifuged, and resuspended to achieve a final concentration of 1.5Â10 6 cells per mL. About 660 mL of this suspension (1.0Â10 6 cells) was used for each scaffold (Tutobone Ò , Tutogen Medical, Neunkirchen, Germany) (Fig. 1A) . The matrices were 9 mm in diameter and 3 mm in height. During the first 6 hours scaffolds were turned in regular intervals to ensure equal distribution of the cell suspension throughout. With this technique a seeding efficiency of 90% was reached.
For static cultivation, cell-matrix constructs were transferred to 48-well plates and cultured in Dulbecco's modified Eagle's medium (DMEM) with high glucose, containing 10% fetal bovine serum (FBS) and 40 IU/mL penicillin/ streptomycin for either 12 hours or 14 days in a humidified atmosphere of 95% air with 5% CO 2 at 378C. Medium was changed every 2 days throughout the culture period.
Dynamic cultivation was performed in bioreactors (Gradient container, Minucells Minutissue, Weinheim, Germany) with cylindrical flow chambers (Fig. 1B, C) . In this experimental setup Hepes buffer (4-(2-Hydroxyethyl)-1-piperazinethansulfonic acid, 25 mM) was added to the culture medium. Each chamber contained a cassette for one cell-matrix construct, sealed by two neoprene rings and held in place by two outside clamps. Bioreactors were connected by silicone tubes to both fresh medium and waste reservoirs. The high permeability of silicone for CO 2 and oxygen allowed for sufficient gas exchange. Flow through each chamber was driven by multichannel roller pumps (Ismatec, IPC, Switzerland), with each flow chamber on its own independent pumping system. In the bioreactor, media flowed through the scaffold from bottom to top to prevent air trapping (Fig. 1C) .
Flow perfusion culture systems were assembled using sterile techniques in a laminar flow hood. Cell-matrix constructs were seeded, placed in the cassettes, and sealed. Systems were placed on a heating plate (378C) and covered with a styrofoam box. Scaffolds were cultured at a medium flow rate of 18.1 mL/minute.
Experimental design and surgical procedure
A total of 24 (six per group) six-to eight-week-old athymic nude mice (nu/nu; Harlan Winkelmann, Borchen, Germany) were used in this study. The study was approved by the Government Committee of Upper Bavaria, and all animals were cared for following guidelines of the LMU Munich for the care and use of laboratory animals.
Following anesthesia using an intramuscular injection of a fentanyl-medetomidin-midazolam mixture, two pouches were prepared subcutaneously by blunt dissection. In one group, cell-matrix constructs that had been statically cultivated for 12 hours were implanted left and scaffolds without hMSC were implanted right paravertebrally. In the second group, matrices cultivated for 14 days under static or flow perfusion conditions, respectively, were used.
After 2 weeks and 12 weeks, scaffolds including the surrounding tissue and organs (brain, heart, lung, liver, kidney, spleen, and testis) were retrieved. One half of the harvested scaffolds were embedded in methylmethacrylate (MMA, Merck, Germany) for histological evaluation, and the other half and the organs were used for molecular analysis.
Histological analysis
Harvested implants were fixated in a formaldehyde/ methanol solution containing 64% methanol, 35% formalde-1060 hyde, and 1% sucrose in phosphate buffered saline (PBS) for 48 hours, dehydrated in a graded series of ethanol, and embedded in MMA. Following polymerization, 4 mm thick sections were prepared of each implant using a microtome technique polycut ( Jung, Heidelberg, Germany). Sections were stained with paragon and investigated using a light microscope (Axioskop, Zeiss, Jena, Germany). Digital images were obtained using a 3CCD color video camera (Sony) and processed on a personal computer with KS 400 (Zeiss). Sections were independently evaluated and graded by three observers judging the extent of inflammatory reaction, necrosis, granulation tissue, the occurrence of adipose tissue, neovascularization, and osteoclasts. The grading scale ranged from 1 to 5 according to van Gaalen et al.
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Molecular analysis
Extraction of DNA. The isolation of DNA from the harvested samples was performed with QiAmp blood and tissue kit (Qiagen, Hilden, Germany) according to the manufacturer's directions. Briefly said, DNA contained in the lysed samples was absorbed onto a silica matrix, and cell debris was removed by washing with QIAamp washing buffer. Finally, the DNA was collected by elution in distilled water.
Conventional DNA PCR. Detection of human DNA (hDNA) within the scaffolds and organs of the mice was confirmed by polymerase chain reaction (PCR). We amplified an 850 bp fragment of the a-satellite region of the human chromosome 17 using primers corresponding to the primer pair 17a1 (5 0 GGG ATA ATT TCA GGT GAC TAA ACa G 3 0 ) and 17a2 (5 0 TTC CGT TTA GTT AGG TGC AGT TAT C 3 0 ) as previously described by Becker et al.
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Each reaction mixture with an end volume of 50 mL contained 250 ng of human genomic DNA, 200 mM of each nucleotide (GTP, ATP, TTP, and CTP), 250 mM of each primer, 2.5 units Taq polymerase, and Q-Solution (Qiagen) with a definite concentration of 15 mM MgCl 2 .
An initial denaturation for 3 minutes at 948C was followed by 40 cycles of 30 seconds each at 948C. Then annealing was performed for 1 minute, followed by a polymerase reaction at 728C for another minute. Finally, 10 minutes of polymerization and an interruption of the reaction by cooling down to 48C completed the cycle. Amplified DNA fragments were transferred onto a 1.75% agarose gel and divided by electrophoresis. After staining with ethidium bromide, gels were analyzed using ultraviolet light.
Isolated DNA from hMSC serving as positive control and DNA extracted from murine fibroblasts serving as negative control ran with every PCR. To prove a reliable sensitivity, the genomic DNA of a cell mixture containing both murine fibroblasts and hMSC was determined with each PCR (1Â10 6 murine fibroblasts þ 10 hMSC and 1Â10 6 murine fibroblasts þ 1 hMSC).
Quantitative real-time PCR (qRT-PCR) on genomic DNA. The quantitative determination of hDNA in the samples was performed by qRT-PCR (LightCycler System, Roche, Mannheim, Germany) using SYBR Green I for detection. A specific human primer set from Search-LC (Heidelberg, Germany) was used (Sense Primer: 5 0 AAC ATG GTG AAA CCC CGT CTC 3 0 ; Anti-Sense Primer: 5 0 TGC AGT GGC GCG ATC TTG 3 0 ). The final volume of each PCR reaction was 20 mL, with 10 mL containing 5 ng genomic DNA in Aqua dest. and 10 mL of a PCR Mix (6 mL PCR grade water, 2 mL of primer pair, and 2 mL of LightCycler Fast Start DNA Master SYBR Green I; Roche).
Each PCR cycle consisted of a 10-second denaturation at 958C followed by an annealing phase of 10 seconds initially at 688C with a transition to 588C in steps of 0.58C per cycle. Elongation was performed at 728C for 16 seconds, during which fluorescence intensity was measured in each cycle. The temperature transition rate of all steps was 208C per second. Following PCR cycling, samples were denatured again at 958C and cooled down to 588C for 10 seconds. To confirm specificity, a melting curve analysis was performed by continuous measurements of the fluorescence intensity while heating the sample to 958C with a temperature transition rate of 0.18C per second. Serial dilution steps of human genomic DNA in 10 mL aqua dest. (60 ng, 6 ng, 0.6 ng, 
Statistical analysis
Correlation analysis was performed using the nonparametric Wilcoxon signed rank test for histological results and the parametric t-test for results of the quantitative PCR. Statistical differences were considered significant when p < 0.05.
RESULTS
Histological findings
After an implantation period of 2 weeks an incipient ingrowth of fibrous tissue was seen histologically. In both treated and blank scaffolds many leukocytes indicating an inflammatory reaction as well as partial necrosis were to be seen (Figs. 2, and 3) .
During the 12 weeks that followed implantation, further ingrowth of the surrounding tissue into the scaffolds occurred. In all seeded and unseeded scaffolds multinucleated giant cells were seen lying on the surface. The increase in osteoclasts compared to 2 weeks after implantation was statistically significant (Fig. 3) . Most of them were seen aligned along the edge of the blank scaffolds. The initial inflammatory reaction, as seen in the 2-week groups, was steadily decreasing until 12 weeks. Instead, more and more scar tissue was viewable, particularly in the middle of the constructs, over time. Further, more adipose tissue was found within loose fibrous connective tissue in all scaffolds. Most of the adipose tissue was detectable within the cell-matrix constructs in the groups with static cultivation, either for 12 hours or 14 days. The increase in adipose tissue in all groups after 12 weeks was statistically significant compared to 2 weeks. In all groups, newly formed vessels could be detected throughout the whole scaffold after 12 weeks. All in all, apart from fat cell formation, no differences regarding tissue reaction as a result of varying culture conditions were seen (Figs. 2  and 3 ).
Semiquantitative PCR
As internal controls we could detect up to 10 hMSC in a pool of 10 6 murine cells. In all explanted composites hDNA was found at all time points equally. No hDNA could be detected in blank scaffolds (Fig. 4A) . Moreover, we did not detect hDNA in any of the explanted organs at any time point (Fig. 4B) . After 2 weeks of implantation hDNA was seen in the soft tissue surrounding the implanted cell-matrix constructs irrespective of the type and duration of in vitro cultivation.
Quantitative PCR (LightCycler)
With RT-PCR a significant decrease in human cells on cell-matrix constructs could be detected after 2 weeks of implantation compared to the amount of initially seeded cells. In the group with statically cultivated scaffolds over 14 days, there was a further significant decrease in human cells after 12 weeks. In the scaffolds statically cultured for 12 hours this decrease was not significant. In the dynamically cultivated group no further decrease in human cells was seen (Fig. 5) .
DISCUSSION
In this study we evaluated the performance of hMSC seeded in bioresorbable and biocompatible scaffolds following subcutaneous implantation over a period of 12 weeks. There was an ingrowth of surrounding host tissue in all groups over time. Regardless of the culture conditions, multinucleated giant cells attached to the surface of the scaffold, which corresponds to the results of other studies. 16 Loose fibrous connective tissue could be detected mainly at the edge and granulation tissue at the center of the scaffolds. The appearance of adipocytes was especially prominent in the groups cultured under static conditions for either 12 hours or 14 days.
Although human cells are frequently used, one remaining problem is their detection in xenotransplantation. However, we could differentiate between implanted hMSC and ingrowing murine cells using RT-PCR. The hMSC were detectable until 12 weeks after implantation in the previously seeded scaffolds. Other studies failed to detect stem cells after 6 weeks by RT-PCR or in situ hybridization, although new bone formation was seen. 17, 18 This might be explained by the missing sensitivity of the method or by the fact that human bone marrow stem cells (hBMSC) labelled with digoxigenin lose their specific properties needed for detection once they are differentiated into osteoblasts. In xenotransplanation it is important to detect implanted stem cells even at a very low level because unwanted cell growth must be ruled out. Although cell death occurred in our study, the PCR was sensitive enough to detect even 10 hMSC. The highly repetitive sequences of the a-satellite centromer region of human chromosome 17 are highly specific for human tissues and allow for detection of even smallest amounts of hDNA. 13 Dilution studies showed that the DNA amount of 10 hMSC was detectable in a pool of 10 6 murine fibroblasts. The quantitative PCR showed that the amount of cells significantly decreased 2 weeks after implantation compared to the initial amount of seeded cells. After 12 weeks there was a further significant decrease in cells in the group that had been statically cultured for 14 days, whereas in the dynamically cultured group the amount of cells remained stable. We presume that under dynamic culture conditions cells form an extracellular matrix (ECM), which prevents them 1062 from further cell death after 2 weeks. Holtorf et al. reported that rat MSC build a mineralized matrix and therefore differentiate toward the osteogenic lineage after dynamic cultivation even without the influence of additional osteogenic supplements. Further, cells are located throughout the whole scaffold, whereas under static culture conditions they are mainly localized in the perimeter of the scaffold. 19 In contrast to other studies, we could not detect any differentiation toward the osteoblastic lineage. 12, [20] [21] [22] Accordingly, no new bone or cartilage formation in the statically or dynamically cultivated groups could be noted. A higher density of cells seeded on the relatively large scaffolds might have had a positive influence on osteoblastic differentiation. Another reason for the difference might be the use of a different cell type in combination with a biological scaffold. Especially for MSC a comparison of experimental outcomes is rather difficult because of varied tissue sources and methodologies of cell preparations. Therefore, the International Society for Cellular Therapy proposed the adherence to plastic, the expression of specific surface antigen, and the multipotent differentiation potential as three minimal criteria to define MSC. 23 To be comparable with other results we used commercially available hMSC, which have quantitatively less progenitor cells than BMSC gained from bone marrow but fulfill the defined criteria.
Further, the osteogenically stimulating medium causes an in vitro differentiation toward the osteogenic lineage of hMSC. Also, dynamic compared to static cultivation of FIG. 2. Paragon-stained MMA-embedded sections 2 weeks (A, D, G, J) and 12 weeks (B, C, E, F, H, I, K, and L) after subcutaneous implantation. Independent of the kind of cultivation, 2 weeks after implantation, mainly inflammation (þ), necrosis (*), and granulation tissue were detectable. Twelve weeks after implantation, there was a decrease in the initial inflammation reaction and an ingrowth of the surrounding tissue with neovascularization (D). Adipose tissue (#) was mainly detectable in statically cultured groups. Color images available online at www.liebertpub.com/ten. osteogenic-stimulated cell-matrix constructs enhances the formation of an ECM in vitro, which facilitates more new bone formation in vivo.
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Although we tested the culture setup in vitro (unpublished data), we assume that the dynamic cultivation setup in flow chambers used in the present study is not sufficient to stimulate hMSC in vitro for differentiation processes in order to form new bone in a heterotopic site. While the bioreactor itself is comparable to the flow perfusion system introduced by Bancroft et al., 11 we used nonrecirculated media supply without addition of osteogenic supplements. We also used a significantly lower flow rate. In comparison to the setup used by Wang et al., 24 who also cultured without stimulating supplements, we used a different bioreactor system and lower flow rates.
Instead of osteogenic differentiation we observed adipose tissue in the seeded scaffolds, which was especially prominent in the groups cultured under static conditions. However, the origin of the adipocytes remains unclear: they may be either the differentiated hMSC or the differentiated precursor cells from the murine host. Our results suggest that static conditions in vitro may permit differentiation toward the adipogenic lineage of hMSC in larger extents than dynamic conditions. Further, it is possible that the implantation of a relatively small amount of differentiated precursor cells may enable considerable further fat cell formation by the host in vivo as has been described in recent fat engineering approaches. 25, 26 The size of the scaffold may be responsible for rapid cell death mainly during the first 2 weeks after implantation and for the lack of bone formation. Although many newly formed vessels were seen after an implantation period of 12 weeks, the results of the quantitative analysis by RT-PCR showed a noticeable decrease in hMSC 2 weeks after implantation. We believe that the death of hMSC mainly occurs during the first hours of implantation and can be attributed to the lack of vascular supply with insufficient nutrient supply by diffusion. These data also correlate with other studies where no new bone formation was seen in large unvascularized bony defects. 27 Although the critical size of ectopic implants did not exceed 3.5 mm, 6 the scaffolds used seemed to be oversized for the relatively poorly vascularized subcutaneous tissue.
Poor adhesion properties of the scaffold or missing differentiation possibilities can be ruled out, because we previously demonstrated new matrix formation after seeding scaffolds in dynamic culture systems for over 6 weeks in vitro (unpublished data). On the other hand, it cannot be ruled out that immunologic reactions, as seen histologically particularly after 2 weeks, lead to early cell death even though athymic nude mice were used. This thesis is supported by the studies of Mc Bride et al., who showed a decrease in cells after intracerebral injection into athymic animals when using hMSC, while the initial amount of injected murine MSC remained unaltered. 28 Other studies have demonstrated that hMSC were detectable in bone marrow as well as in other organs such as lung and spleen after intravenous injection. 13, 29, 30 We showed that no unwanted cell migration from the implanted composites into the organs of the host occurred following ectopic implantation. The question if unwanted cell migration could occur over the vascular network present in bone marrow remains unanswered despite its relevance for orthotopic implantation.
In summary, we established an experimental model that allows for testing the influence of different cell populations and the onset of cell differentiation, as well as evaluate the performance of various scaffolds regarding their integration in vivo after subcutaneous implantation. The PCR described allows a sensitive and specific detection of human cells following xenotransplantation. The RT-PCR using LightCycler methodology allows a reliable quantification of hMSC within the implanted scaffolds. In this study we were not able to detect a significant advantage of dynamic cultivation with respect to the formation of new bone following subcutaneous implantation. We believe that in addition to in vitro culture conditions, the surface properties of the used scaffold, the use of an adequate cell type, and the amount of implanted cells as well as their grade of differentiation are at least as important for new bone formation in vivo.
